MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis.
BACKGROUND:In 2013, approximately 480,000 people developed active multidrug-resistant tuberculosis (MDR-TB), while only 97,000 started MDR-TB treatment. We sought to estimate the impact of improving access to MDR-TB diagnosis and treatment, under multiple diagnostic algorithm and treatment regimen s...
Main Authors: | Emily A Kendall, Andrew S Azman, Frank G Cobelens, David W Dowdy |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5342197?pdf=render |
Similar Items
-
Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)
by: Natasha F. Sabur, et al.
Published: (2021-03-01) -
Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
by: Monadil H. Ali, et al.
Published: (2019-07-01) -
Linkage of presumptive multidrug resistant tuberculosis (MDR-TB) patients to diagnostic and treatment services in Cambodia.
by: Sokhan Khann, et al.
Published: (2013-01-01) -
Correlates of treatment outcomes of multidrug-resistant tuberculosis (MDR-TB): a systematic review and meta-analysis
by: Akçakir, Yasemin
Published: (2010) -
Management of multidrug resistant tuberculosis (MDR-TB) – Monitoring is the key to successful
by: J.S. Akshata, et al.
Published: (2016-04-01)